Decision Support for Medical Experts

© Fraunhofer IGD
The creation of individual cohorts using a tree view that includes all available attributes. Analysts can arrange dashboards to gain insights into current cohorts and achieve a precise separation of the data.

The search for more effective methods to improve the diagnosis and prediction of diseases is more urgent than ever.
Current processes are time-consuming, expensive, and often not accurate enough. This results in treatment delays and places an unnecessary financial burden on the healthcare system.

For patients with chronic, painful diseases such as psoriatic arthritis or vasculitis, it often takes months to find the optimal medication and dosage. However, innovative approaches can offer solutions: non-invasive biomarkers have the potential to enable faster and less risky diagnoses. At the same time, for example, psychological trauma in children or hemorrhagic complications (bleeding) can be prevented when diagnoses are based on blood or urine biomarkers instead of relying on liver biopsies.

To discover such biomarkers, close collaboration between physicians and medical data analysts is essential in order to make the right decisions. However, this exchange is often characterized by misunderstandings due to inefficient processes and differing perspectives. As a result, the efficient translation of medical knowledge into clinical practice is slowed down. This not only impacts patient well-being but also puts additional strain on the healthcare system.

By promoting efficient collaboration between medical data analysts and physicians, we can accelerate healthcare delivery. These advancements could significantly improve the quality, speed, and cost of diagnosis and treatment, contributing to more precise and personalized healthcare. By increasing the efficiency of collaboration, we can transform the healthcare sector so that research findings are developed and implemented more quickly—allowing patients to receive better and less invasive care. Together, we can fundamentally change how diseases are diagnosed and treated—for the benefit of all patients.

© Fraunhofer IGD
Using mouse selection across multiple panels, physicians are enabled to analyze predefined cohorts—primarily healthy vs. diseased subjects.
© Fraunhofer IGD
A detailed overview with statistics, omics feature analyses, and sample analyses provides the foundation for discovering new patterns and dependencies between individual features.
© Fraunhofer IGD
A specific view offers physicians more information about the omics features in relation to the given cohorts.

Our products are developed to support data analysts, clinical researchers, and medical experts in accelerating and optimizing decision-making.
For clinical researchers, our solutions streamline the analysis of fragmented clinical trials by reducing inconsistencies in data processing and enabling integrated analysis. This leads to the creation of comprehensive visual reports that provide deeper insights into clinical data and enable more informed, collaborative decision-making.